← Back to Clinical Trials
Recruiting NCT07133919

NCT07133919 Effect of AI-Supported Child-Friendly Communication on Dental Anxiety in Pediatric Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07133919
Status Recruiting
Phase
Sponsor Çanakkale Onsekiz Mart University
Condition Caries, Dental
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2025-10-15
Primary Completion 2026-01

Eligibility & Interventions

Sex All sexes
Min Age 7 Years
Max Age 12 Years
Study Type INTERVENTIONAL
Interventions
AI-Assisted Child-Friendly CommunicationTraditional Behavior Management Techniques

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2025-10-15 with a primary completion date of 2026-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study compares the effects of traditional behavior management techniques and AI-assisted child-friendly communication on dental anxiety, physiological stress, and pain perception during local anesthesia in healthy children aged 6-12. The aim is to evaluate the effectiveness of AI-supported communication tools in reducing anxiety and improving comfort in pediatric dental treatments, potentially enhancing clinical outcomes and advancing technology use in pediatric dentistry.

Eligibility Criteria

Inclusion Criteria: * Children volunteers and their parents/legal guardians who have read and signed the informed consent form and agreed to participate in the study * Systemically healthy children aged 6-12 years in the mixed dentition period * Children requiring restorative dental procedures (including pulpotomy, pulp capping, or composite restorations) on mandibular teeth under inferior alveolar nerve block local anesthesia * Children who are attending their first dental visit and demonstrate behavior rated as 2 (negative) or 3 (positive) according to the Frankl Behavior Rating Scale (Categories: 1 - definitely negative; 2 - negative; 3 - positive; 4 - definitely positive) Behaviors will be categorized as positive (+) or negative (-) based on the Frankl Behavior Rating Scale (Wright's modification) * Children receiving local anesthesia for the first time Exclusion Criteria: * Children volunteers and their parents/legal guardians who read the informed consent form but declined to participate in the study * Children with systemic diseases requiring continuous medication * Children with mental or cognitive impairments, as well as those with visual or hearing disabilities * Children who, after oral prophylaxis at the first visit, exhibit "definitely negative" (Frankl 1) or "definitely positive" (Frankl 4) behavior according to the Frankl Behavior Rating Scale * Children with previous experience of local anesthesia

Contact & Investigator

Central Contact

Burak Çarıkçıoğlu, Associate Professor

✉ carikcioglub@gmail.com

📞 00905054956091

Frequently Asked Questions

Who can join the NCT07133919 clinical trial?

This trial is open to participants of all sexes, aged 7 Years or older, up to 12 Years, studying Caries, Dental. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07133919 currently recruiting?

Yes, NCT07133919 is actively recruiting participants. Contact the research team at carikcioglub@gmail.com for enrollment information.

Where is the NCT07133919 trial being conducted?

This trial is being conducted at Çanakkale, Turkey (Türkiye).

Who is sponsoring the NCT07133919 clinical trial?

NCT07133919 is sponsored by Çanakkale Onsekiz Mart University. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology